Crossmark

Infusion of two-dose mesenchymal stem cells is more effective than a single dose in a dilated cardiomyopathy rat model by upregulating indoleamine 2,3-dioxygenase expression

Crossref DOI link: https://doi.org/10.1186/s13287-022-03101-w

Published Online: 2022-08-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gong, Chenyi

Chang, Lei

Sun, Xuan

Qi, Yu

Huang, Rong

Chen, Ke

Wang, Bin

Kang, Lina

Wang, Lian

Xu, Biao
Funding

Funding for this research was provided by:

Natural Science Foundation of China (81870204, 82070366)

Medical Science and technology development Foundation, Nanjing Department of Health (ZKX19017)
License Information

Text and Data Mining valid from 2022-08-12

Version of Record valid from 2022-08-12
More Information

Article History

Received: 29 March 2022

Accepted: 28 July 2022

First Online: 12 August 2022

Declarations

:

: All procedures involving human-derived materials were approved by the Research Ethics Board of Nanjing Drum Tower Hospital (Permit Number: 2017-161-01). Animal experiments were performed, according to the guidelines of the National Institutes of Health and approved by the Institutional Ethics Committee of Nanjing Drum Tower Hospital (Approval No. 20210116).

: Not applicable.

: All authors declare that they have no competing interest.

Document is current

Any future updates will be listed below